• Western blot analysis of various lysates using PLAG1 Rabbit polyclonal antibody (STJ11102811) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.
  • Western blot analysis of lysates from U-87MG cells, using PLAG1 Rabbit polyclonal antibody (STJ11102811) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 60s.

Anti-PLAG1 antibody (33-288) (STJ11102811)

SKU:
STJ11102811

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-PLAG1 (33-288) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PLAG1
Gene ID: 5324
Uniprot ID: PLAG1_HUMAN
Immunogen Region: 33-288
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 33-288 of human PLAG1 (NP_002646.2).
Immunogen Sequence: NFPCQLCDKAFNSVEKLKVH SYSHTGERPYKCIQQDCTKA FVSKYKLQRHMATHSPEKTH KCNYCEKMFHRKDHLKNHLH THDPNKETFKCEECGKNYNT KLGFKRHLALHAATSGDLTC KVCLQTFESTGVLLEHLKSH AGKSSGGVKEKKHQCEHCDR RFYTRKDVRRHMVVHTGRKD FLCQYCAQRFGRKDHLTRHM KKSHNQELLKVKTEPVDFLD PFTCNVSVPIKDELLPVMS
Tissue Specificity Expressed in fetal tissues such as lung, liver and kidney. Not detected or weak detection in normal adult tissues, but highly expressed in salivary gland with benign or malignant pleiomorphic adenomas with or without 8q12 aberrations, with preferential occurrence in benign tumors.
Post Translational Modifications Sumoylated with SUMO1.which inhibits transcriptional activity, but does not affect nuclear localization. Blockers of sumoylation pathway such as SENP3 and inactive UBE2I increases transcriptional capacity. Sumoylation is increased in the presence of PIAS1. Acetylated by lysine acetyltransferase EP300.which activates transcriptional capacity. Lysine residues that are sumoylated also seem to be target for acetylation.
Function Transcription factor whose activation results in up-regulation of target genes, such as IGFII, leading to uncontrolled cell proliferation: when overexpressed in cultured cells, higher proliferation rate and transformation are observed. Other target genes such as CRLF1, CRABP2, CRIP2, PIGF are strongly induced in cells with PLAG1 induction. Proto-oncogene whose ectopic expression can trigger the development of pleomorphic adenomas of the salivary gland and lipoblastomas. Overexpression is associated with up-regulation of IGFII, is frequently observed in hepatoblastoma, common primary liver tumor in childhood. Cooperates with CBFB-MYH11, a fusion gene important for myeloid leukemia.
Protein Name Zinc Finger Protein Plag1
Pleiomorphic Adenoma Gene 1 Protein
Cellular Localisation Nucleus
Strong Nucleolar Localization When Sumoylation Is Inhibited
Alternative Antibody Names Anti-Zinc Finger Protein Plag1 antibody
Anti-Pleiomorphic Adenoma Gene 1 Protein antibody
Anti-PLAG1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance